The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

NCT01298869 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease, Stage IV (Severe)
Chronic Kidney Disease, Stage V

Interventions

BIOLOGICAL: HPV-6/11/16/18 vaccine

Sponsor

Chulalongkorn University